Literature DB >> 12163323

Tea consumption and ovarian cancer risk: a case-control study in China.

Min Zhang1, Colin W Binns, Andy H Lee.   

Abstract

To investigate whether tea consumption has an etiological association with ovarian cancer, a case-control study was conducted in China during 1999-2000. The cases were 254 patients with histologically confirmed epithelial ovarian cancer. The 652 controls comprised 340 hospital visitors, 261 non-neoplasm hospital outpatients, and 51 women recruited from the community. Information on the frequency, type, and duration of tea consumption was collected by personal interview using a validated questionnaire. The risk of ovarian cancer for tea consumption was assessed using adjusted odds ratios based on multivariate logistic regression analysis, accounting for confounding demographic, lifestyle, and familial factors including hormonal status and family ovarian cancer. The ovarian cancer risk declined with increasing frequency and duration of overall tea consumption. The adjusted odds ratio was 0.39 for those drinking tea daily and 0.23 for those drinking tea for >30 years, compared with nontea drinkers. The dose response relationships were significant, and the inverse association with ovarian cancer was observed for green tea consumption. We concluded that increasing frequency and duration of tea drinking, especially green tea, can reduce the risk of ovarian cancer. However, the protective effects of black tea and Oolong tea need to be additionally investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163323

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Diet and risk of ovarian cancer in the California Teachers Study cohort.

Authors:  Ellen T Chang; Valerie S Lee; Alison J Canchola; Christina A Clarke; David M Purdie; Peggy Reynolds; Hoda Anton-Culver; Leslie Bernstein; Dennis Deapen; David Peel; Rich Pinder; Ronald K Ross; Daniel O Stram; Dee W West; William Wright; Argyrios Ziogas; Pamela L Horn-Ross
Journal:  Am J Epidemiol       Date:  2007-01-08       Impact factor: 4.897

2.  Effect of green tea (camellia sinensis l.) leaf extract on reproductive system of adult male albino rats.

Authors:  Shyamal Kanti Das; Soumendra Nath Karmakar
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

3.  Modulation of MPP+ uptake by tea and some of its components in Caco-2 cells.

Authors:  R Monteiro; C Calhau; F Martel; A Faria; N Mateus; I Azevedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-22       Impact factor: 3.000

Review 4.  Green and black tea in relation to gynecologic cancers.

Authors:  Lesley M Butler; Anna H Wu
Journal:  Mol Nutr Food Res       Date:  2011-05-19       Impact factor: 5.914

5.  A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.

Authors:  Guodong Li; Wenwei Lin; Juan J Araya; Taosheng Chen; Barbara N Timmermann; Grace L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-04       Impact factor: 4.219

6.  Green tea consumption and glutathione S-transferases genetic polymorphisms on the risk of adult leukemia.

Authors:  Ping Liu; Min Zhang; Xing Xie; Jie Jin; C D'Arcy J Holman
Journal:  Eur J Nutr       Date:  2015-11-17       Impact factor: 5.614

7.  The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.

Authors:  Amal Shervington; Vidya Pawar; Sharad Menon; Dipti Thakkar; Rahima Patel
Journal:  Mol Biol Rep       Date:  2008-06-26       Impact factor: 2.316

8.  Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.

Authors:  Huaping Chen; Charles N Landen; Yuanyuan Li; Ronald D Alvarez; Trygve O Tollefsbol
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

Review 9.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Katja Boehm; Francesca Borrelli; Edzard Ernst; Gabi Habacher; Shao Kang Hung; Stefania Milazzo; Markus Horneber
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Flavonoid intake and ovarian cancer risk in a population-based case-control study.

Authors:  Margaret A Gates; Allison F Vitonis; Shelley S Tworoger; Bernard Rosner; Linda Titus-Ernstoff; Susan E Hankinson; Daniel W Cramer
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.